Alvotech Balance Sheet Health
Financial Health criteria checks 0/6
Alvotech has a total shareholder equity of $-932.5M and total debt of $960.2M, which brings its debt-to-equity ratio to -103%. Its total assets and total liabilities are $950.1M and $1.9B respectively.
Key information
-103.0%
Debt to equity ratio
US$960.16m
Debt
| Interest coverage ratio | n/a |
| Cash | US$11.16m |
| Equity | -US$932.49m |
| Total liabilities | US$1.88b |
| Total assets | US$950.09m |
Recent financial health updates
No updates
Recent updates
Alvotech: Consider Buying As Positive Q1 Earnings Release Likely
Apr 25Alvotech (NASDAQ:ALVO) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Apr 03
Alvotech (NASDAQ:ALVO) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Mar 24Analysts Just Shaved Their Alvotech (NASDAQ:ALVO) Forecasts Dramatically
Sep 03Positive Sentiment Still Eludes Alvotech (NASDAQ:ALVO) Following 27% Share Price Slump
May 05Shareholders Shouldn’t Be Too Comfortable With Alvotech's (NASDAQ:ALVO) Strong Earnings
Nov 23Fuji Pharma files for approval of biosimilar candidate in Japan
Oct 17Alvotech and STADA launch Humira biosimilar in Switzerland
Sep 22Alvotech GAAP EPS of -$1.02, revenue of $40.1M
Aug 31Alvotech starts pharmacokinetic study for its biosimilar to Amgen's bone disease drugs
Jul 20Icelandic biosimilars developer Alvotech initiated with a hold rating by Deutsche Bank
Jul 01Financial Position Analysis
Short Term Liabilities: ALVO has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: ALVO has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: ALVO has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: ALVO's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ALVO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ALVO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.